Panelists discuss how clinicians should interpret Clinical Dementia Rating-Sum of Boxes (CDR-SB) score changes by correlating ...

Panelists discuss how amyloid-targeting therapies for Alzheimer disease represent a breakthrough drug class that works by ...

National Infertility Awareness Week highlights that infertility impacts both men and women, is more prevalent among Black and ...

Accessing equitable health care is an ongoing struggle in the US for minority communities due to historical pretexts with new ...

Panelists discuss how uncomplicated urinary tract infections (UTIs) are typically managed with empiric short-course ...

Experts discuss the most promising applications of bispecifics in solid tumors and other emerging therapeutic areas.

Experts discuss how payer and reimbursement considerations affect access to bispecific therapies in different practice settings.

Experts discuss how institutions can address the resource and bandwidth challenges that come with administering complex therapies like bispecifics.

Experts discuss the role of technology, such as electronic health record (EHR) integration, in improving the operationalization of bispecific antibodies.

Experts discuss why it is critical to have standardized protocols in place for managing cytokine release syndrome (CRS) in patients receiving bispecific antibodies, outlining the key components of an ...

The West Health-Gallup Healthcare Indices Study indicates that approximately 29 million people are unable to afford or access ...

New findings may help patients with low to moderate risk of tumor lysis syndrome while reducing the burden for hematologists.